Genmab — Maj 2017

[E_L]

reimbursed in 15 countires

[E_L]

16.000 patients treated so far

[E_L]

25+ clinical studies

[E_L]

future growth drivers Subc
and solid tumors

[E_L]

"one of most exciting in our portfolio"

[Sukkeralf]

Nice E L - and thanks for these one-liners. Hopefully more to come

[JohnW]

Yes, E L , thanks for your updates. Keep 'em coming.

[AaBforever]

Måske for store forventninger til dette event..:-(

[Vitus]

Der er godt nok langt til 1400 nu

[digafarm]

Ro på, det er vitterligt bare et lille skvulp.

[jkj]

wells fargo aftvinger svar på hvilket produkt, kan vækste mest, af de 5 mega blogbuster, svar. Darzalex

[dohk]

Darzalex...the make over of
pharmaceutical group

[henrik48]

Very grateful that someone can give us headlines from the webcast...ty @ EL..

[E_L]

i think he said "Darzalex could become the main growth driver for our pharmaceutical group". that is quite a statement.

[Bulder]

så nu kommer der nok et bud på hele pibetøjet. Tænk på al den royalty, de kan spare.

[OHW]

keep on dreaming

[bibob]

If he did say that, its big words.

[bibob]

Genmab should have had an option to buy back the licence to Darzalex.

[E_L]

I refer to OHW's comment; keep dreaming haha

[E_L]

but still, some think Genmab must have gotten something for changing the royalty from 20-28% to 12-20% -if that story
is true. But nobody knows what